These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27466490)

  • 61. Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient.
    Kuwahara Y; Iehara T; Ichise E; Katsumi Y; Ouchi K; Tsuchiya K; Miyachi M; Konishi E; Sasajima H; Nakamura S; Fumino S; Tajiri T; Johann PD; FrÜhwald MC; Yoshida T; Okuda T; Hosoi H
    Anticancer Res; 2020 Nov; 40(11):6159-6170. PubMed ID: 33109553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
    Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
    Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.
    Machado I; Noguera R; Santonja N; Donat J; Fernandez-Delgado R; Acevedo A; Baragaño M; Navarro S
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):150-8. PubMed ID: 19770707
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
    Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
    Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
    DeCristofaro MF; Betz BL; Wang W; Weissman BE
    Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Rhabdoid tumours].
    Vasovčák P; Puchmajerová A; Křepelová A
    Klin Onkol; 2012; 25 Suppl():S27-9. PubMed ID: 22920203
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Malignant rhabdoid tumor of the liver presented with initial tumor rupture.
    Kachanov D; Teleshova M; Kim E; Dobrenkov K; Moiseenko R; Usychkina A; Filin A; Semenkov A; Mitrofanova A; Konovalov D; Shamanskaya T; Novichkova G; Varfolomeeva S
    Cancer Genet; 2014 Sep; 207(9):412-4. PubMed ID: 24894493
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
    Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
    Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors.
    Oberlick EM; Rees MG; Seashore-Ludlow B; Vazquez F; Nelson GM; Dharia NV; Weir BA; Tsherniak A; Ghandi M; Krill-Burger JM; Meyers RM; Wang X; Montgomery P; Root DE; Bieber JM; Radko S; Cheah JH; Hon CS; Shamji AF; Clemons PA; Park PJ; Dyer MA; Golub TR; Stegmaier K; Hahn WC; Stewart EA; Schreiber SL; Roberts CWM
    Cell Rep; 2019 Aug; 28(9):2331-2344.e8. PubMed ID: 31461650
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature.
    Krishnan C; Vogel H; Perry A
    Hum Pathol; 2014 Jan; 45(1):185-8. PubMed ID: 24034858
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
    Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
    Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
    Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
    Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
    Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G
    Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.